| 1 | Cholesteatoma | 31.8% |
| 2 | Parakeratosis | 31.8% |
| 3 | Erythroplasia | 27.9% |
| 4 | Aberrant Crypt Foci | 27.9% |
| 5 | Porokeratosis | 27% |
| 6 | Keratoderma, Palmoplantar | 27% |
| 7 | Xeroderma Pigmentosum | 24.3% |
| 8 | Pyoderma Gangrenosum | 24.3% |
| 9 | Skin Neoplasms | 22.8% |
| 10 | Xeroderma | 22.7% |
| 11 | Leukoplakia | 21.1% |
| 12 | Lupus Erythematosus, Cutaneous | 21.1% |
| 13 | Panniculitis | 21.1% |
| 14 | Systemic Scleroderma | 21.1% |
| 15 | Morphea | 21.1% |
| 16 | Breast Diseases | 20.9% |
| 17 | Dermatitis | 20.9% |
| 18 | Exanthema | 20.9% |
| 19 | Facial Dermatoses | 20.9% |
| 20 | Hair Diseases | 20.9% |
| 21 | Hand Dermatoses | 20.9% |
| 22 | keratoacanthoma | 20.9% |
| 23 | Nail Diseases | 20.9% |
| 24 | Photosensitivity Disorders | 20.9% |
| 25 | Prurigo | 20.9% |
| 26 | Pyoderma | 20.9% |
| 27 | Rosacea | 20.9% |
| 28 | Sebaceous Gland Diseases | 20.9% |
| 29 | Skin Diseases, Vesiculobullous | 20.9% |
| 30 | Skin Ulcer | 20.9% |
| 31 | Sweat Gland Diseases | 20.9% |
| 32 | Skin Diseases, Papulosquamous | 20.9% |
| 33 | Skin Diseases, Vascular | 20.9% |
| 34 | Acneiform Eruptions | 20.9% |
| 35 | Ocular Rosacea | 20.9% |
| 36 | Subcorneal pustular dermatosis | 20.9% |
| 37 | Erythematotelangiectatic Rosacea | 20.9% |
| 38 | Papulopustular Rosacea | 20.9% |
| 39 | Chronic Actinic Dermatitis | 20.9% |
| 40 | Barrett Esophagus | 20.7% |
| 41 | Acne Vulgaris | 20.3% |
| 42 | Contact Dermatitis | 20.3% |
| 43 | Eczema | 20.3% |
| 44 | Erythema Multiforme | 20.3% |
| 45 | Intertrigo | 20.3% |
| 46 | Neurodermatitis | 20.3% |
| 47 | Rhinophyma | 20.3% |
| 48 | Perioral Dermatitis | 20.3% |
| 49 | Acne | 20.3% |
| 50 | Sebaceous Gland Neoplasms | 20.3% |
| 51 | Papillon-Lefevre Disease | 19.9% |
| 52 | Dermatitis, Phototoxic | 17.9% |
| 53 | Pityriasis Lichenoides et Varioliformis Acuta | 17.9% |
| 54 | Pityriasis Lichenoides | 17.9% |
| 55 | Phototoxicity | 17.9% |
| 56 | Foot Ulcer | 17.6% |
| 57 | Dermatitis, Atopic | 17.3% |
| 58 | Epidermolysis Bullosa | 17.3% |
| 59 | Breast Cyst | 17.2% |
| 60 | Urticaria Pigmentosa | 16.7% |
| 61 | Dermatitis Herpetiformis | 16.4% |
| 62 | Foot Diseases | 16.4% |
| 63 | Acrodermatitis | 16.2% |
| 64 | Gianotti-Crosti Syndrome | 16.2% |
| 65 | Skin Abnormalities | 15.8% |
| 66 | Skin Diseases, Infectious | 15.8% |
| 67 | Pigmentation Disorders | 15.8% |
| 68 | Lymphomatoid Granulomatosis | 15.7% |
| 69 | Mastocytosis | 15.6% |
| 70 | Panniculitis, Lupus Erythematosus | 15.6% |
| 71 | Lipomatosis | 15.5% |
| 72 | Pruritus | 15.5% |
| 73 | Erythema | 15.5% |
| 74 | Necrolytic Migratory Erythema | 15.5% |
| 75 | Cutaneous Fistula | 15.5% |
| 76 | Nephrogenic Fibrosing Dermopathy | 15.5% |
| 77 | Nephrogenic Systemic Fibrosis | 15.5% |
| 78 | Necrobiosis Lipoidica Diabeticorum | 15.1% |
| 79 | Dermatitis, Irritant | 15% |
| 80 | Acne Conglobata | 15% |
| 81 | Dermatitis, Photoallergic | 14.8% |
| 82 | Hamartoma | 14.6% |
| 83 | Neoplasms, Hormone-Dependent | 14.6% |
| 84 | Neoplasms, Multiple Primary | 14.6% |
| 85 | Paraneoplastic Syndromes | 14.6% |
| 86 | Neoplasms, Second Primary | 14.6% |
| 87 | Hyperkeratosis, Epidermolytic | 13.8% |
| 88 | Mastocytoma | 13.8% |
| 89 | Anhidrosis | 13.6% |
| 90 | Pressure Ulcer | 13.6% |
| 91 | Folliculitis | 13.6% |
| 92 | Foot Dermatoses | 13.6% |
| 93 | Gynecomastia | 13.6% |
| 94 | Hypertrichosis | 13.6% |
| 95 | Hypohidrosis | 13.6% |
| 96 | Hypotrichosis | 13.6% |
| 97 | Leg Ulcer | 13.6% |
| 98 | Miliaria | 13.6% |
| 99 | Parapsoriasis | 13.6% |
| 100 | Pityriasis | 13.6% |
| 101 | Psoriasis | 13.6% |
| 102 | Sweet Syndrome | 13.6% |
| 103 | Hidradenitis | 13.6% |
| 104 | Onycholysis | 13.6% |
| 105 | Miliaria Rubra | 13.6% |
| 106 | Hyperpigmentation | 13.6% |
| 107 | Lichenoid Eruptions | 13.6% |
| 108 | Chloracne | 13.6% |
| 109 | Dermatomyositis | 13.6% |
| 110 | Lupus Erythematosus, Discoid | 13.6% |
| 111 | Scleroderma, Limited | 13.6% |
| 112 | Carcinoma, Lobular | 13.5% |
| 113 | Erythema Induratum | 13% |
| 114 | Leukoplakia, Oral | 12.8% |
| 115 | Ichthyosis, X-Linked | 12.6% |
| 116 | Breast Neoplasms, Male | 12.6% |
| 117 | Triple Negative Breast Neoplasms | 12.6% |
| 118 | Sjogren-Larsson Syndrome | 12.5% |
| 119 | Dermatitis, Occupational | 12.5% |
| 120 | Diaper Rash | 12.4% |
| 121 | Cutis Laxa | 12.3% |
| 122 | Connective Tissue Diseases | 12.2% |
| 123 | Dermatitis, Allergic Contact | 12% |
| 124 | Erythema Infectiosum | 11.9% |
| 125 | Exanthema Subitum | 11.8% |
| 126 | Carcinoma 256, Walker | 11.8% |
| 127 | Erythema Nodosum | 11.6% |
| 128 | Ectodermal Dysplasia | 11.5% |
| 129 | Aplasia Cutis Congenita | 11.5% |
| 130 | Pseudoxanthoma Elasticum | 11.2% |
| 131 | Carcinoma, Ehrlich Tumor | 11.1% |
| 132 | Dermoid Cyst | 11.1% |
| 133 | Toxic Epidermal Necrolysis | 11.1% |
| 134 | Stevens-Johnson Syndrome | 11.1% |
| 135 | Carcinoma, Lewis Lung | 11.1% |
| 136 | Cyst | 10.9% |
| 137 | Neoplastic Processes | 10.9% |
| 138 | Neoplastic Syndromes, Hereditary | 10.9% |
| 139 | Pregnancy Complications, Neoplastic | 10.9% |
| 140 | Multiple Endocrine Neoplasia | 10.9% |
| 141 | Neoplasms, Experimental | 10.7% |
| 142 | Tinea Capitis | 10.7% |
| 143 | Onychomycosis | 10.7% |
| 144 | Neoplasms, Neuroepithelial | 10.7% |
| 145 | Gliomatosis cerebri | 10.7% |
| 146 | Medulloblastoma | 10.5% |
| 147 | Acantholysis | 10.3% |
| 148 | Pemphigoid, Benign Mucous Membrane | 10.3% |
| 149 | Pemphigus | 10.3% |
| 150 | Piedra | 10.3% |
| 151 | Sunburn | 10.3% |
| 152 | Myxoid cyst | 10.3% |
| 153 | Argyria | 10.2% |
| 154 | Hirsutism | 10.2% |
| 155 | Lactation Disorder | 10.2% |
| 156 | Mastitis | 10.2% |
| 157 | Urticaria | 10.2% |
| 158 | Neuroectodermal Tumors | 10.2% |
| 159 | Melanoma, Experimental | 10.2% |
| 160 | Lichen Planus | 10.1% |
| 161 | Melanosis | 10.1% |
| 162 | Chloasma | 10.1% |
| 163 | Pityriasis Rosea | 10.1% |
| 164 | Pityriasis Rubra Pilaris | 10.1% |
| 165 | Vitiligo | 10.1% |
| 166 | Lichen Nitidus | 10.1% |
| 167 | Adiposis Dolorosa | 10.1% |
| 168 | Pruritus Vulvae | 10.1% |
| 169 | Granuloma Annulare | 10.1% |
| 170 | Pruritus Ani | 10% |
| 171 | Ecthyma | 10% |
| 172 | melanoma | 9.9% |
| 173 | Paraneoplastic Encephalomyelitis | 9.7% |
| 174 | Trophoblastic Neoplasms | 9.6% |
| 175 | Leukemia, Experimental | 9.5% |
| 176 | Mammary Neoplasms, Experimental | 9.5% |
| 177 | Abdominal Neoplasms | 9.3% |
| 178 | Follicular cyst | 9.3% |
| 179 | Head and Neck Neoplasms | 9.3% |
| 180 | leukemia | 9.3% |
| 181 | Mucocele | 9.3% |
| 182 | Neoplasms, Germ Cell and Embryonal | 9.3% |
| 183 | Neoplasms, Glandular and Epithelial | 9.3% |
| 184 | Pilonidal Cyst | 9.3% |
| 185 | Soft Tissue Neoplasms | 9.3% |
| 186 | Thoracic Neoplasms | 9.3% |
| 187 | Thyroglossal Cyst | 9.3% |
| 188 | Synovial Cyst | 9.3% |
| 189 | Germ Cell Cancer | 9.3% |
| 190 | Carcinosarcoma | 9.2% |
| 191 | Hemangiosarcoma | 9.2% |
| 192 | Leukemia L1210 | 9.2% |
| 193 | Leukemia P388 | 9.2% |
| 194 | lymphangiosarcoma | 9.2% |
| 195 | Acanthoma | 9.2% |
| 196 | Adenoma, Acidophil | 9.2% |
| 197 | Ganglioneuroma | 9.2% |
| 198 | Glioma | 9.2% |
| 199 | Malignant Glioma | 9.2% |
| 200 | Meningioma | 9.1% |
| 201 | Carcinoid Tumor | 8.9% |
| 202 | Neurilemmoma | 8.9% |
| 203 | Hutchinson's Melanotic Freckle | 8.9% |
| 204 | Melanoma, Amelanotic | 8.9% |
| 205 | Behcet Syndrome | 8.8% |
| 206 | Sarcoma 180 | 8.8% |
| 207 | Sarcoma, Experimental | 8.8% |
| 208 | Choriocarcinoma | 8.5% |
| 209 | Hidradenitis Suppurativa | 8.5% |
| 210 | Neoplasms, Radiation-Induced | 8.5% |
| 211 | Astrocytoma | 8.5% |
| 212 | Ependymoma | 8.5% |
| 213 | oligodendroglioma | 8.5% |
| 214 | Ganglioglioma | 8.5% |
| 215 | gliosarcoma | 8.5% |
| 216 | Anaplastic astrocytoma | 8.5% |
| 217 | Anaplastic Oligodendroglioma | 8.5% |
| 218 | Acanthosis Nigricans | 8.4% |
| 219 | Alopecia Areata | 8.4% |
| 220 | Lentigo | 8.4% |
| 221 | Basal cell carcinoma | 8.3% |
| 222 | Carcinoma, Papillary | 8.3% |
| 223 | Squamous cell carcinoma | 8.3% |
| 224 | Chondrosarcoma | 8.3% |
| 225 | Craniopharyngioma | 8.3% |
| 226 | Cystadenoma | 8.3% |
| 227 | leiomyosarcoma | 8.3% |
| 228 | liposarcoma | 8.3% |
| 229 | Mesothelioma | 8.3% |
| 230 | synovial sarcoma | 8.3% |
| 231 | Neuroectodermal Tumor, Melanotic | 8.3% |
| 232 | Angiomyolipoma | 8.3% |
| 233 | Clear Cell Sarcoma of Soft Tissue | 8.3% |
| 234 | Alveolar Soft Part Sarcoma | 8.3% |
| 235 | Neuroendocrine Tumors | 8.3% |
| 236 | Sarcoma, Myeloid | 8.3% |
| 237 | Carcinoma, Basal Cell | 8.3% |
| 238 | Malignant Carcinoid Syndrome | 8.3% |
| 239 | Peutz-Jeghers Syndrome | 8.3% |
| 240 | Dermatomycoses | 8.2% |
| 241 | Mucocutaneous Lymph Node Syndrome | 8.2% |
| 242 | Skin Diseases, Bacterial | 8.2% |
| 243 | Glioblastoma | 8.1% |
| 244 | Neuroblastoma | 8.1% |
| 245 | Glioblastoma Multiforme | 8.1% |
| 246 | Drug Eruptions | 8.1% |
| 247 | Lipodystrophy | 8.1% |
| 248 | Livedo Reticularis | 8.1% |
| 249 | Malignant Atrophic Papulosis | 8.1% |
| 250 | Multiple Endocrine Neoplasia Type 1 | 8.1% |
| 251 | Leukemia, Radiation-Induced | 8% |
| 252 | Polyarteritis Nodosa | 8% |
| 253 | Takayasu Arteritis | 8% |
| 254 | Ganglioneuroblastoma | 8% |
| 255 | Cystadenocarcinoma | 7.9% |
| 256 | Fibrosarcoma | 7.9% |
| 257 | Osteosarcoma | 7.9% |
| 258 | Mucoepidermoid Carcinoma | 7.9% |
| 259 | Albinism | 7.8% |
| 260 | Tinea Pedis | 7.7% |
| 261 | Alopecia | 7.7% |
| 262 | Sweating, Gustatory | 7.7% |
| 263 | Androgenetic Alopecia | 7.7% |
| 264 | Auriculotemporal Syndrome | 7.7% |
| 265 | Adenofibroma | 7.7% |
| 266 | Fibroadenoma | 7.7% |
| 267 | Malignant Fibrous Histiocytoma | 7.7% |
| 268 | Erythema Chronicum Migrans | 7.7% |
| 269 | Lice Infestations | 7.6% |
| 270 | Varicose Ulcer | 7.6% |
| 271 | Galactorrhea | 7.5% |
| 272 | Tuberous Sclerosis | 7.4% |
| 273 | Bowen's Disease | 7.4% |
| 274 | Paraganglioma | 7.4% |
| 275 | Rhabdomyosarcoma | 7.4% |
| 276 | Giant Cell Tumor of Bone | 7.4% |
| 277 | Thymoma | 7.4% |
| 278 | Leukemia, Plasma Cell | 7.3% |
| 279 | Digestive System Neoplasms | 7.3% |
| 280 | Endocrine Gland Neoplasms | 7.3% |
| 281 | Eye Neoplasms | 7.3% |
| 282 | Nervous System Neoplasms | 7.3% |
| 283 | Dermatofibrosarcoma | 7.2% |
| 284 | Dermatofibrosarcoma Protuberans | 7.2% |
| 285 | Bone neoplasms | 7% |
| 286 | Lymphocele | 7% |
| 287 | Pancreatic Cyst | 7% |
| 288 | Hematologic Neoplasms | 7% |
| 289 | Retinoblastoma | 7% |
| 290 | Pheochromocytoma | 7% |
| 291 | Alveolar rhabdomyosarcoma | 7% |
| 292 | Collagen Diseases | 7% |
| 293 | Mixed Connective Tissue Disease | 7% |
| 294 | Mucinoses | 7% |
| 295 | Dupuytren Contracture | 6.9% |
| 296 | Histiocytic Disorders, Malignant | 6.9% |
| 297 | Mediastinal Cyst | 6.9% |
| 298 | Nail-Patella Syndrome | 6.9% |
| 299 | Neoplasm Invasiveness | 6.9% |
| 300 | Neoplasm Metastasis | 6.9% |
| 301 | Neoplasm Recurrence, Local | 6.9% |
| 302 | Parathyroid Neoplasms | 6.9% |
| 303 | Parovarian Cyst | 6.9% |
| 304 | Pericardial Cyst | 6.9% |
| 305 | Peritoneal Neoplasms | 6.9% |
| 306 | Splenic Neoplasms | 6.9% |
| 307 | Thymic Cyst | 6.9% |
| 308 | Thyroid Neoplasm | 6.9% |
| 309 | Thyroid carcinoma | 6.9% |
| 310 | Carcinogenesis | 6.9% |
| 311 | Metastasis | 6.9% |
| 312 | Carcinoma, Pancreatic Ductal | 6.9% |
| 313 | Adenoma | 6.8% |
| 314 | Ameloblastoma | 6.8% |
| 315 | Angiokeratoma | 6.8% |
| 316 | Carcinoma | 6.8% |
| 317 | Chordoma | 6.8% |
| 318 | Hemangioma | 6.8% |
| 319 | hemangiopericytoma | 6.8% |
| 320 | Lymphangioma | 6.8% |
| 321 | Mesenchymoma | 6.8% |
| 322 | Nevus | 6.8% |
| 323 | Retroperitoneal Neoplasms | 6.8% |
| 324 | Teratoma | 6.8% |
| 325 | Porphyrias, Hepatic | 6.8% |
| 326 | Hepatoblastoma | 6.8% |
| 327 | Mixed Tumor, Mullerian | 6.8% |
| 328 | Germinoma | 6.8% |
| 329 | Teratocarcinoma | 6.8% |
| 330 | Angiofibroma | 6.8% |
| 331 | Sarcoma | 6.8% |
| 332 | Epithelioma | 6.8% |
| 333 | Carcinoid Heart Disease | 6.8% |
| 334 | Composite Lymphoma | 6.7% |
| 335 | Acoustic Neuroma | 6.6% |
| 336 | Mycetoma | 6.6% |
| 337 | Basal Cell Nevus Syndrome | 6.5% |
| 338 | Lichen Planus, Oral | 6.4% |
| 339 | Vipoma | 6.3% |
| 340 | Tracheal Neoplasms | 6.3% |
| 341 | Hydatidiform Mole | 6.2% |
| 342 | Liver Neoplasms, Experimental | 6.2% |
| 343 | Neurofibrosarcoma | 6.1% |
| 344 | Larva Migrans | 6.1% |
| 345 | Leishmaniasis | 6.1% |
| 346 | Molluscum Contagiosum | 6.1% |
| 347 | Nephroblastoma | 6.1% |
| 348 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 349 | Angioedema | 6.1% |
| 350 | Onchocerciasis | 6.1% |
| 351 | Chromoblastomycosis | 6% |
| 352 | Dermatophytosis | 6% |
| 353 | Sporotrichosis | 6% |
| 354 | Tinea | 6% |
| 355 | Tinea Versicolor | 6% |
| 356 | Trichophytosis | 6% |
| 357 | Hyalohyphomycosis | 6% |
| 358 | Acute Generalized Exanthematous Pustulosis | 6% |
| 359 | Pancreatic Neoplasm | 5.9% |
| 360 | Optic Nerve Glioma | 5.9% |
| 361 | Endometrial Stromal Sarcoma | 5.7% |
| 362 | Adenocarcinoma | 5.6% |
| 363 | Carcinoma in Situ | 5.6% |
| 364 | Carcinoma, Transitional Cell | 5.6% |
| 365 | Phyllodes Tumor | 5.6% |
| 366 | Dysgerminoma | 5.6% |
| 367 | Hemangioendothelioma | 5.6% |
| 368 | Lipoma | 5.6% |
| 369 | Myoma | 5.6% |
| 370 | Myxoma | 5.6% |
| 371 | Neuroma | 5.6% |
| 372 | Papilloma | 5.6% |
| 373 | Pseudomyxoma Peritonei | 5.6% |
| 374 | Seminoma | 5.6% |
| 375 | Papillomatosis | 5.6% |
| 376 | Angiolipoma | 5.6% |
| 377 | Myelolipoma | 5.6% |
| 378 | Neoplasms, Bone Tissue | 5.6% |
| 379 | Neoplasms, Fibrous Tissue | 5.6% |
| 380 | Smooth Muscle Tumor | 5.6% |
| 381 | Adenomatosis, Pulmonary | 5.6% |
| 382 | Adenomatous Polyps | 5.6% |
| 383 | Carcinoma, Large Cell | 5.6% |
| 384 | Carcinoma, Small Cell | 5.6% |
| 385 | Desmoplastic Small Round Cell Tumor | 5.6% |
| 386 | Chondroma | 5.6% |
| 387 | Enchondroma | 5.6% |
| 388 | Thyroid Nodule | 5.6% |
| 389 | Hepatocellular Adenoma | 5.6% |
| 390 | insulinoma | 5.5% |
| 391 | Lymphangioleiomyomatosis | 5.5% |
| 392 | Lymphoma | 5.5% |
| 393 | Cartilage Diseases | 5.5% |
| 394 | Rheumatism | 5.5% |
| 395 | Chondromalacia | 5.5% |
| 396 | Corpus Luteum Cyst | 5.4% |
| 397 | Ovarian Cysts | 5.4% |
| 398 | Gastrinoma | 5.4% |
| 399 | Glucagonoma | 5.4% |
| 400 | Esophageal Neoplasms | 5.3% |
| 401 | Lupus Erythematosus, Systemic | 5.3% |
| 402 | Overlap syndrome | 5.3% |
| 403 | Limbic Encephalitis | 5.2% |
| 404 | Mouth Neoplasms | 5.2% |
| 405 | Central Nervous System Neoplasms | 5.2% |
| 406 | Vascular Neoplasms | 5.2% |
| 407 | Thymus Neoplasms | 5.2% |
| 408 | Warts | 5.1% |
| 409 | Genital Neoplasms, Female | 5.1% |
| 410 | Pancreatic Pseudocyst | 5.1% |
| 411 | Plasmacytoma | 5.1% |
| 412 | Malignant histiocytosis | 5% |
| 413 | Lymphatic Metastasis | 5% |
| 414 | Neoplasms, Unknown Primary | 5% |
| 415 | Leukemic Infiltration | 5% |
| 416 | Histiocytic sarcoma | 5% |
| 417 | Neoplasm Micrometastasis | 5% |
| 418 | Adenoid Cystic Carcinoma | 5% |
| 419 | fibroma | 5% |
| 420 | Fibromatosis | 5% |
| 421 | Osteoblastoma | 5% |
| 422 | Osteoma | 5% |
| 423 | Rhabdomyoma | 5% |
| 424 | Chondromatosis | 5% |
| 425 | Adenocarcinoma, Clear Cell | 5% |
| 426 | Cholangiocarcinoma | 5% |
| 427 | Cervical Intraepithelial Neoplasia | 5% |
| 428 | Hemangioblastoma | 5% |
| 429 | Lymphoma, Extranodal NK-T-Cell | 5% |
| 430 | Candidiasis, Chronic Mucocutaneous | 5% |
| 431 | Cutaneous Candidiasis | 5% |
| 432 | Leishmaniasis, Cutaneous | 5% |
| 433 | Eczema Herpeticum | 5% |
| 434 | Adenomatous Polyposis Coli | 5% |
| 435 | Erysipelas | 5% |
| 436 | Serum Sickness | 5% |
| 437 | Staphylococcal Skin Infections | 5% |
| 438 | Variegate Porphyria | 5% |
| 439 | Acute intermittent porphyria | 5% |
| 440 | Porphyria Cutanea Tarda | 5% |
| 441 | Erythrasma | 5% |
| 442 | Arthritis, Psoriatic | 4.9% |
| 443 | Fusariosis | 4.9% |
| 444 | CREST Syndrome | 4.9% |
| 445 | Leydig Cell Tumor | 4.8% |
| 446 | Fibromatosis, Aggressive | 4.7% |
| 447 | Fibromatosis, Abdominal | 4.7% |
| 448 | Klatskin Tumor | 4.7% |
| 449 | Prolactinoma | 4.7% |
| 450 | Growth Hormone-Secreting Pituitary Adenoma | 4.7% |
| 451 | Lambert-Eaton Myasthenic Syndrome | 4.6% |
| 452 | Testicular Neoplasms | 4.6% |
| 453 | Choledochal Cyst | 4.6% |
| 454 | Scleromyxedema | 4.5% |
| 455 | Hereditary Angioedema Type III | 4.4% |
| 456 | Hereditary Angioedema Types I and II | 4.4% |
| 457 | Giant Cell Arteritis | 4.4% |
| 458 | Temporal Arteritis | 4.4% |
| 459 | Mesoblastic Nephroma | 4.3% |
| 460 | Adrenocortical carcinoma | 4.2% |
| 461 | Meningeal Neoplasms | 4.2% |
| 462 | Angioedemas, Hereditary | 4.2% |
| 463 | Adrenal Gland Neoplasms | 4.2% |
| 464 | Gastrointestinal Neoplasms | 4.2% |
| 465 | Genital Neoplasms, Male | 4.2% |
| 466 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 467 | Liver neoplasms | 4.2% |
| 468 | Uveal Neoplasms | 4.2% |
| 469 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 470 | Epidermodysplasia Verruciformis | 4.2% |
| 471 | Herpes Labialis | 4.2% |
| 472 | Diabetic Foot | 4.1% |
| 473 | Urologic Neoplasms | 4.1% |
| 474 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 475 | granulosa cell tumor | 4.1% |
| 476 | Carcinoma, Ovarian Epithelial | 4.1% |
| 477 | Staphylococcal Scalded Skin Syndrome | 4.1% |
| 478 | Spinal Neoplasms | 4.1% |
| 479 | Bone Marrow Neoplasms | 4.1% |
| 480 | Hodgkin Disease | 4% |
| 481 | Lymphoma, Non-Hodgkin | 4% |
| 482 | Polycystic Ovary Syndrome | 4% |
| 483 | Palatal Neoplasms | 3.9% |
| 484 | Nose Neoplasms | 3.8% |
| 485 | Blastomycosis | 3.7% |
| 486 | Meningeal Carcinomatosis | 3.7% |
| 487 | Mastocytosis, Systemic | 3.7% |
| 488 | Leukemia, Myeloid, Chronic-Phase | 3.7% |
| 489 | HIV-Associated Lipodystrophy Syndrome | 3.7% |
| 490 | Renal Cell Carcinoma | 3.7% |
| 491 | Papillary Renal Cell Carcinoma | 3.7% |
| 492 | carbuncle | 3.7% |
| 493 | Myelitis, Transverse | 3.6% |
| 494 | Condylomata Acuminata | 3.6% |
| 495 | Furunculosis | 3.5% |
| 496 | furuncle | 3.5% |
| 497 | Carcinoma, Endometrioid | 3.5% |
| 498 | Denys-Drash Syndrome | 3.5% |
| 499 | Impetigo | 3.5% |
| 500 | Ear Neoplasms | 3.4% |
| 501 | Eyelid Neoplasms | 3.4% |
| 502 | Lung Neoplasms | 3.4% |
| 503 | Mesenteric Panniculitis | 3.4% |
| 504 | Panniculitis, Peritoneal | 3.4% |
| 505 | Pleural Neoplasms | 3.4% |
| 506 | Tietze's Syndrome | 3.4% |
| 507 | Orbital Cellulitis | 3.4% |
| 508 | Sturge-Weber Syndrome | 3.4% |
| 509 | Cellulitis | 3.4% |
| 510 | Myxedema | 3.4% |
| 511 | Rhinoscleroma | 3.4% |
| 512 | Cell Transformation, Viral | 3.4% |
| 513 | Brain Neoplasms | 3.4% |
| 514 | Salivary Gland Neoplasms | 3.4% |
| 515 | Spinal Cord Neoplasms | 3.4% |
| 516 | Tongue Neoplasms | 3.4% |
| 517 | Gastrointestinal Stromal Tumors | 3.4% |
| 518 | Nasopharyngeal carcinoma | 3.4% |
| 519 | Primary amyloidosis | 3.4% |
| 520 | Pituitary Adenoma | 3.3% |
| 521 | Pituitary Neoplasms | 3.3% |
| 522 | Hemangioma, Cavernous | 3.3% |
| 523 | Leukemia, T-Cell | 3.3% |
| 524 | Uterine Neoplasms | 3.3% |
| 525 | Vaginal Neoplasms | 3.3% |
| 526 | Vulvar Neoplasms | 3.3% |
| 527 | Uterine Cancer | 3.3% |
| 528 | Leukemia, B-Cell | 3.3% |
| 529 | Fallopian Tube Neoplasms | 3.3% |
| 530 | neurofibroma | 3.3% |
| 531 | Lymphoma, Follicular | 3.3% |
| 532 | T-Cell Lymphoma | 3.3% |
| 533 | Mantle cell lymphoma | 3.3% |
| 534 | Menkes Kinky Hair Syndrome | 3.3% |
| 535 | Bronchial Neoplasms | 3.1% |
| 536 | Multiple Pulmonary Nodules | 3% |
| 537 | Supratentorial Neoplasms | 3% |
| 538 | Endometrial Neoplasms | 3% |
| 539 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 540 | Leukemia, Large Granular Lymphocytic | 3% |
| 541 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 542 | Lymphoma, T-Cell, Cutaneous | 2.9% |
| 543 | Lymphoma, AIDS-Related | 2.9% |
| 544 | Enteropathy-Associated T-Cell Lymphoma | 2.9% |
| 545 | Primary Effusion Lymphoma | 2.9% |
| 546 | Pharyngeal Neoplasms | 2.9% |
| 547 | ovarian neoplasm | 2.9% |
| 548 | Central Nervous System Cysts | 2.8% |
| 549 | Bile Duct Neoplasms | 2.8% |
| 550 | gallbladder neoplasm | 2.8% |
| 551 | Intestinal Neoplasms | 2.8% |
| 552 | Penile Neoplasms | 2.8% |
| 553 | Prostatic Neoplasms | 2.8% |
| 554 | Stomach Neoplasms | 2.8% |
| 555 | Brain Stem Neoplasms | 2.8% |
| 556 | Osteochondritis | 2.8% |
| 557 | Polymyalgia Rheumatica | 2.8% |
| 558 | Mycosis Fungoides | 2.8% |
| 559 | Lymphomatoid Papulosis | 2.8% |
| 560 | Plasmablastic lymphoma | 2.8% |
| 561 | Polycythemia Vera | 2.7% |
| 562 | Osteogenesis Imperfecta | 2.7% |
| 563 | Choroid Plexus Papilloma | 2.7% |
| 564 | Keloid | 2.7% |
| 565 | Noonan Syndrome | 2.5% |
| 566 | Hypopharyngeal Neoplasms | 2.5% |
| 567 | Pleural Effusion, Malignant | 2.5% |
| 568 | Hypopharyngeal Cancer | 2.5% |
| 569 | Waldenstrom Macroglobulinemia | 2.5% |
| 570 | Multiple Myeloma | 2.5% |
| 571 | Laryngeal neoplasm | 2.5% |
| 572 | Parotid Neoplasms | 2.5% |
| 573 | Prostatic Neoplasms, Castration-Resistant | 2.5% |
| 574 | Nelson Syndrome | 2.5% |
| 575 | Bladder Neoplasm | 2.4% |
| 576 | Kidney Neoplasm | 2.4% |
| 577 | Ureteral Neoplasms | 2.4% |
| 578 | Urethral Neoplasms | 2.4% |
| 579 | Tonsillar Neoplasms | 2.3% |
| 580 | Cerebellar Neoplasms | 2.3% |
| 581 | Rheumatoid Arthritis | 2.3% |
| 582 | Juvenile arthritis | 2.3% |
| 583 | Marfan Syndrome | 2.3% |
| 584 | Zollinger-Ellison syndrome | 2.2% |
| 585 | Lupus Nephritis | 2.2% |
| 586 | Homocystinuria | 2.2% |
| 587 | Cecal Neoplasms | 2.1% |
| 588 | Duodenal Neoplasms | 2.1% |
| 589 | Burkitt Lymphoma | 2.1% |
| 590 | Rheumatoid Nodule | 2% |
| 591 | Sezary Syndrome | 2% |
| 592 | Radicular Cyst | 2% |
| 593 | Laryngomalacia | 2% |
| 594 | Appendiceal Neoplasms | 2% |
| 595 | Colonic Neoplasms | 2% |
| 596 | Rectal Neoplasms | 2% |
| 597 | Pectus carinatum | 2% |
| 598 | Nasopharyngeal Neoplasms | 1.9% |
| 599 | Colorectal Neoplasms | 1.8% |
| 600 | Paranasal Sinus Neoplasms | 1.7% |
| 601 | Felty Syndrome | 1.7% |
| 602 | Bronchomalacia | 1.7% |
| 603 | Tracheomalacia | 1.7% |
| 604 | Anus Neoplasms | 1.7% |
| 605 | Sigmoid Neoplasms | 1.7% |
| 606 | Maxillary Sinus Neoplasms | 1.5% |
| 607 | Rheumatoid Vasculitis | 1.4% |
| 608 | Mucopolysaccharidosis III | 1.4% |
| 609 | Sicca Syndrome | 1.2% |
| 610 | Sjogren's Syndrome | 1.2% |
| 611 | Lupus Vasculitis, Central Nervous System | 1% |
| 612 | Mucopolysaccharidosis II | 1% |
